US Patent 8436183 Synthetic multimerizing agents
Patent 8436183 was granted and assigned to Ariad Pharmaceuticals, Inc. on May, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 19 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Nov, 2023
Golden AI
Edits made to:
Article (+232 characters)
Article
Patent abstract
New compounds are disclosed for multimerizing immunophilins and proteins containing immunophilin or immunophilin-related domains. The compounds are of the formulaM-L-Qwhere M is a synthetic ligand for an FKBP protein.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Dennis A. Holt0
Edgardo Laborde0
Tao Guo0
Terence P. Keenan0
Wu Yang0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08436183 Synthetic multimerizing agents US Patent 8436183 Synthetic multimerizing agents
Infobox
Patent Number
084361830
Patent Number
84361830
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
084361830
Date of Patent
May 7, 2013
0Patent Application Number
133610820
Date Filed
January 30, 2012
0Patent Primary Examiner
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08436183 Synthetic multimerizing agents
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08436183
Date of patent
May 7, 2013
Patent application number
13361082
Date Filed
January 30, 2012
Patent primary examiner
Find more entities like US Patent 8436183 Synthetic multimerizing agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.